Stemming the Tide – Models of Care for Young Adult Survivors of Childhood Cancer


Presentation Description:
Improved rates of survival for children with cancer have resulted in a dramatic escalation of young adult survivors entering POGO’s Provincial Pediatric Oncology AfterCare Program. The current model of care, whereby the vast majority of young adult survivors are cared for in the oncology centers, is therefore rapidly becoming unsustainable. This session will therefore explore a future model(s) of care that would move survivors from an oncology centre-focused model to one that involves other care providers (e.g., family health teams).

Paul Nathan, MD, MSc
Director, AfterCare Program
Division of Hematology/Oncology
Hospital for Sick Children

Dr. Nathan is Director of the AfterCare clinic in the Division of Pediatric Hematology/ Oncology at the Hospital for Sick Children (SickKids). He is a Senior Associate Scientist in the SickKids Research Institute and an Associate Professor of Pediatrics and Health Policy, Management and Evaluation at the University of Toronto. His research is focused on long-term outcomes in survivors of childhood cancer. He studies specific “late effects” of cancer therapy, including cardiac disease and second malignant neoplasms. Much of his research focuses on health care utilization and its relationship with long-term outcomes in adult survivors of childhood cancer. He is a member of several North American research and clinical committees focused on research, clinical care, and policy creation for long-term survivors of childhood cancer, including the Children’s Oncology Group Survivorship and Outcomes Committee, and the Childhood Cancer Survivor Study (CCSS).

Eva Grunfeld, MD, DPhil, CCFP, FCFP
Director, Knowledge Translation Research, Health Services Research Program
Ontario Institute for Cancer Research

Dr. Grunfeld is a physician-scientist and Director of the Knowledge Translation Research Network, Health Services Research Program, at the Ontario Institute for Cancer Research. At the University of Toronto, Dr. Grunfeld holds the post of Giblon Professor and Vice-Chair (Research) at the Department of Family and Community Medicine.
Dr. Grunfeld is a leader in cancer health services and outcomes research. Her research focuses on evaluation and knowledge translation of cancer health services, covering the entire spectrum of cancer control activities. She is internationally recognized for research on integration of care and on cancer outcomes.

Dr. Grunfeld uses a mixed-methods approach including randomized controlled trials (RCTs), qualitative research and outcomes research. Knowledge translation is an integral part of all her research activities. She has conducted several multi-centre RCTs on cancer survivorship which have influenced clinical practice guidelines and policies internationally.

Dr. Grunfeld holds many peer-review grants as Principal Investigator and has served on many committees to further the goals of cancer control in Canada and internationally. From 2004 to 2008 she founded and directed the Cancer Outcomes Research Program at Cancer Care Nova Scotia and Dalhousie University. She obtained her medical degree from McMaster University and doctoral degree from Oxford University.

Jonathan Sussman, MD, CCFP, FRCPC, MSc
Radiation Oncologist
Director, Supportive Care Research Unit
Juravinski Cancer Centre

Dr. Sussman is a Radiation Oncologist at the Jurvanksi Cancer Centre who specializes in the treatment of breast cancer and hematological malignancies. He received his initial training as a family physician. His research interests include trials in the treatment of breast cancer and lymphoma and health services research in models of care with a special focus on improving integration between providers in caring for cancer survivors. He is an Ontario Association of Radiation Oncologists Clinician Scientist and is the Chair of Advisory Committee in the Survivorship Program at Cancer Care Ontario.

*POGO was not granted permission to share  Eva Grunfeld’s and Jonathan Sussman’s slide.

Comments are closed.